Meet the DermaSensor Team

Operational Team

Cody is a bioengineer and entrepreneur that has focused all of his career on bringing new health technologies to physicians and patients. Most recently Cody led commercial efforts for a Silicon Valley medical device screening startup and held BD and commercial strategy roles at Genentech.

Cody Simmons

Chief Executive Officer

Ryan has over 16 years of experience founding and scaling companies in consumer goods, healthcare, and enterprise technologies. Recently, Ryan led the growth for a healthcare supply chain technology and previously ran the international manufacturing and distribution of consumer hardware electronics.

Ryan Freiden

Chief Operations Officer

Larry is a West Point Graduate with 20 years of medical device experience, specializing in building teams and launching disruptive technologies. Most recently, Larry led the sales team at Acessa Health to a successful exit to Hologic during the covid-19 pandemic. His previous organizations include Ethicon Women’s Health and Urology, Interlace Medical, Hologic, and BG Medical.

Larry Anderson

Chief Commercial Officer

Dr. Vivien Nguyen is a pharmacist by training with almost a decade of experience in the medical device and pharmaceutical industry. Vivien has contributed to the successful launches of new products and indications in various therapeutic areas including dermatology, immunology, rheumatology and ophthalmology. Previous employers include Incyte, Novartis, Suneva Medical, and OptumRx.

Vivien Nguyen, PharmD

Director of Medical Affairs

20+ years of healthcare industry experience in Business Development, Sales & Marketing Management, General Management and Director for companies such as HP, Agilent Technologies, Philips Healthcare, Mindray Medical, and Stanley Healthcare, Kevin has extensive experience working with healthcare providers across the Asia Pacific region.

Kevin Scrimshaw

Commercial Director ANZ

Kiran has blended experience in clinical medicine and research in orthopedic surgery at the Cleveland Clinic with an expertise in study protocol design, statistics and data analysis through her MPH program. Most recently she worked in the medical device industry, specifically with regulatory writing for obtaining CE mark for surgical devices.

Kiran Chatha, MD

Clinical and Medical Science Liaison

20 years experience in the health care sector, working with companies such as MSD, National Home Doctor, and Mundipharma. She has been involved with many projects working to identify and reduce treatment gaps and achieve improved patient outcomes. She believes that optimal patient management should be the first priority.

Shannon Whiteley

Territory Business Manager – NSW/ACT

17+ years of experience across multiple industries including pharmaceutical, healthcare, disability and aged care. She has a strong background in account management, BD, operations and entrepreneurship. She is passionate about social change, preventative health, and thinking outside the box to deliver solutions with long-term sustainable value.

Martina Clark

Territory Business Manager – VIC

Cason Hucks is a graduate of Baylor University, where he studied Biology and Biochemistry. While in attendance, he led multiple research projects in the fields of Bioinformatics, Genetics, and Human Physiology. When not in school, Hucks works as an EMT. He is planning to attend medical school in the fall of 2023.

Cason Hucks

Clinical Development Fellow

Board of Directors

Cody Simmons

Chief Executive Officer

Maurice Ferre, MD

Chairman

Ivan Delevic

Director

Christopher Dewey

Director

David Matlin

Director

Scientific Advisory Board

Cristiane Benvenuto, MD

Irving Bigio, PhD

Holly Christman, MD

John Geisse, MD

David Leffell, MD

Giovanni Pellacani, MD

Paul Salmon, FRACP

Todd Thames, MD

80-0009.3

Learn About Our Device

Our History

As two leading entrepreneurs and investors in health technology companies, Dr. Maurice Ferre (co-founder and chairman) and Christopher Dewey (co-founder) identified a fundamental issue with skin cancer screening and lack of access to care for individuals with skin lesions of concern. This was particularly apparent in primary care where early detection of skin cancer is often hampered by limited consultation time and limited dermatology training, leading to a lack of confidence in diagnosing skin cancer.

They founded DermaSensor in 2009 and started collaborating with Dr. Irving Bigio, Professor of Biomedical Engineering at Boston University and one of the top spectroscopy researching in the world. Dr. Bigio is the original inventory and patent holder for Elastic Scattering Spectroscopy (ESS), a key component of the DermaSensor Device.

Since the invention of ESS in 1994, there have been over 1,000 ESS publications and over 50 publications on ESS clinics studies. DermaSensor began ints own skin-specific studies using this technology in 2011 and began its first study on the commercial prototype of the device in 2017.

80-0009.3

Scroll to Top